The prices of imported and domestic medicines have risen slightly this month, according to the Viet Nam Pharmaceutical Companies Association. Among the nearly 4,200 drugs surveyed in Ha Noi, 97 drugs saw price hikes of 6.2 per cent on average, and 19 saw a 4.4 per cent decrease, accounting for 2.3 per cent and 0.4 [...]
Jul 26 2011 | Posted in
Health & Drugs |
Read More »
The Vietnam Drug Administration has mapped out a draft master plan for the development of the drug industry till 2020 with a vision to 2030, with an aim to supply 70% of medicine demand of local people compared to 50% at the moment. The administration said in the draft that Vietnam has 400 pharmaceutical companies, [...]
May 5 2011 | Posted in
Health & Drugs |
Read More »
Three out of 22 drug producers based in Ho Chi Minh City have sought permission from the Department of Health to hike prices by up to 40 percent claiming increased manufacturing costs following last month’s devaluation of the dong. A decision has yet to be made but Pham Khanh Long An, the Department’s deputy director, [...]
Mar 15 2011 | Posted in
Health & Drugs |
Read More »
The State Securities Commission has cancelled the upcoming public offer of 7 million shares of Vien Dong Pharmaceutical Co (DVD) due to the company’s failure to rectify shortcomings relating to its earlier suspension of the issue, the commission announced Tuesday. DVD shares, traded on the HCM City Stock Exchange, responded to the decision yesterday by [...]
Jan 20 2011 | Posted in
Health & Drugs |
Read More »
While the Ministry of Health has created favourable conditions for domestic pharmaceutical companies to expand production, the industry needs to develop a strategy to attract investment, says Minister of Health Nguyen Quoc Trieu. Most domestic pharmaceutical companies simply produce basic medicines but not the more specific, higher value products supplied by foreign-invested ones,said Trieu. Over [...]
Dec 29 2010 | Posted in
Health & Drugs |
Read More »
Three pharmaceutical companies have agreed to pay $421 million for reporting inflated drug prices to the US government, officials said Tuesday. The Justice Department said that Abbott Laboratories, Roxane Laboratories, a US-based subsidiary of a German firm, and German drug maker Braun Medical Inc all agreed to pay the fines. The three companies are accused [...]
Dec 9 2010 | Posted in
Health & Drugs |
Read More »